Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
5.30
+0.43 (8.83%)
At close: Aug 13, 2025, 4:00 PM
5.27
-0.03 (-0.57%)
Pre-market: Aug 14, 2025, 8:58 AM EDT
Puma Biotechnology Employees
Puma Biotechnology had 172 employees as of December 31, 2024. The number of employees decreased by 13 or -7.03% compared to the previous year.
Employees
172
Change (1Y)
-13
Growth (1Y)
-7.03%
Revenue / Employee
$1,384,081
Profits / Employee
$281,692
Market Cap
266.96M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PBYI News
- 5 days ago - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 days ago - Puma Biotechnology, Inc. (PBYI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Puma Biotechnology Reports Second Quarter Financial Results - Business Wire
- 20 days ago - Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial Results - Business Wire
- 7 weeks ago - Puma Biotechnology: Updated Timelines And A Resurgence In Sentiment - Seeking Alpha
- 3 months ago - Puma Biotechnology, Inc. (PBYI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Puma Biotechnology Reports First Quarter Financial Results - Business Wire
- 3 months ago - Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients - GlobeNewsWire